Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 2007;49:784-791
Published online before print February 19, 2007, doi: 10.1161/01.HYP.0000259739.64834.d4
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
49/4/784    most recent
01.HYP.0000259739.64834.d4v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Marfella, R.
Right arrow Articles by Paolisso, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Marfella, R.
Right arrow Articles by Paolisso, G.
Related Collections
Right arrow Cerebrovascular disease/stroke
Right arrow Carotid endarterectomy
Right arrow Oxidant stress
Right arrow Mechanism of atherosclerosis/growth factors
Right arrowRelated Article

(Hypertension. 2007;49:784.)
© 2007 American Heart Association, Inc.


Original Articles

Morning Blood Pressure Surge as a Destabilizing Factor of Atherosclerotic Plaque

Role of Ubiquitin–Proteasome Activity

Raffaele Marfella; Mario Siniscalchi; Michele Portoghese; Clara Di Filippo; Franca Ferraraccio; Concetta Schiattarella; Basilio Crescenzi; Paolo Sangiuolo; Giuseppe Ferraro; Silvio Siciliano; Francesca Cinone; Gennaro Mazzarella; Simone Martis; Mario Verza; Ludovico Coppola; Francesco Rossi; Michele D’Amico; Giuseppe Paolisso

From the Departments of Geriatric and Metabolic Diseases (R.M., M.S., C.S., G.F., F.C., M.V., L.C., G.P.), Experimental Medicine (C.D.F.), and Clinical and Preventive Medicine (F.F., G.M., S.M.) and the Cardiovascular Research Center (R.M., C.D.F., F.R., G.P.), Second University of Naples, Naples, Italy; the Cardiovascular Surgery Unit (M.P., F.R., M.D.), Sassari Hospital, Italy; and the Cardiovascular Surgery Unit (B.C., P.S.) and Cardiology Department (S.S.), Hospital V. Monaldi, Naples, Italy.

Correspondence to Raffaele Marfella, Via Emilio Scaglione 141, 80145 Napoli, Italy. E-mail raffaele.marfella{at}unina2.it

Whether morning blood pressure surge influences the molecular mechanisms of plaque progression toward instability is not known. Recently, we have demonstrated enhanced activity of the ubiquitin–proteasome system in human plaques and evidenced that it is associated with inflammatory-induced plaque rupture. We evaluated the inflammatory infiltration and ubiquitin–proteasome activity in asymptomatic carotid plaques of hypertensive patients with different patterns of morning blood pressure surge. Plaques were obtained from 32 hypertensive patients without morning blood pressure surge and 28 with morning blood pressure surge enlisted to undergo carotid endarterectomy for extracranial high-grade (>70%) internal carotid artery stenosis. Plaques were analyzed for macrophages, T-lymphocytes, human leukocyte antigen–DR+cells, ubiquitin–proteasome activity, nuclear factor-{kappa}B, inhibitor kB-ß, tumor necrosis factor-{alpha}, nitrotyrosine, matrix metalloproteinase-9, and collagen content (immunohistochemistry and ELISA). Compared with plaques obtained from hypertensive patients without morning blood pressure surge, plaques from with morning blood pressure surge had more macrophages, T-lymphocytes, human leukocyte antigen–DR+cells (P<0.001), ubiquitin-proteasome activity, tumor necrosis factor-{alpha}, nuclear factor-kB (P<0.001), nitrotyrosine, and matrix metalloproteinase-9 (P<0.01), along with a lesser collagen content and IkB-ß levels (P<0.001). Enhanced ubiquitin–proteasome activity in atherosclerotic lesions of patients with morning blood pressure surge is associated with inflammatory-dependent unstable plaque phenotype. These data suggest a potential interplay between morning blood pressure surge and ubiquitin–proteasome activity in atherosclerosis pathophysiology.


Key Words: morning blood pressure • atherosclerotic plaque • inflammation • ubiquitin–proteasome activity


Related Article:

Vascular Damage in Exaggerated Morning Surge in Blood Pressure
Kazuomi Kario
Hypertension 2007 49: 771-772. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Cardiovasc ResHome page
J. Herrmann, L. O. Lerman, and A. Lerman
On to the road to degradation: atherosclerosis and the proteasome
Cardiovasc Res, November 14, 2009; (2009) cvp333v2.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
O. Tsukamoto, T. Minamino, and M. Kitakaze
Functional alterations of cardiac proteasomes under physiological and pathological conditions
Cardiovasc Res, September 4, 2009; (2009) cvp282v2.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Marfella, C. Di Filippo, M. Portoghese, F. Ferraraccio, B. Crescenzi, M. Siniscalchi, M. Barbieri, C. Bologna, M. R. Rizzo, F. Rossi, et al.
Proteasome Activity as a Target of Hormone Replacement Therapy-Dependent Plaque Stabilization in Postmenopausal Women
Hypertension, April 1, 2008; 51(4): 1135 - 1141.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Kario
Vascular Damage in Exaggerated Morning Surge in Blood Pressure
Hypertension, April 1, 2007; 49(4): 771 - 772.
[Full Text] [PDF]